Active Cancer NIHR-supported project Lungs & Breathing

A Phase 1, Open-label, Multicenter Study of ZW171 in Participants With Advanced or Metastatic Ovarian Cancer, Non-small Cell Lung Cancer (NSCLC), and Other Mesothelin Expressing Cancers

Funder NIHR (part of DHSC)
Recipient organisation NIHR Biomedical Research Centre at the Royal Marsden and the ICR Source-published name: NIHR Royal Marsden Biomedical Research Centre
NIHR support Recorded as supported by this research centre
Period Feb 2025 — Dec 2027

About this grant

This summary is based on the grant title only — the full abstract was not available.

No substantive source abstract was published for this research project funded by NIHR.

Researchers

Anna Minchom (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

A Phase 1, Open-label, Multicentre Study of ZW171 in Participants With Advanced or Metastatic Ovarian Cancer, Non-small Cell Lung Cancer (NSCLC), and Other Mesothelin Expressing Cancers.
A Phase 2b, open-label, single-arm study of ZW25 monotherapy in subjects with advanced or metastatic HER2 amplified biliary tract cancers
A Phase I, Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Ascending Doses of AZD0156 Monotherapy or in Combination with either Cytotoxic Chemotherapies or Novel Anti-Cancer Agents in Patients with Advanced Malignancies
An open-label Phase 1/2a study of oral BAL101553 in adult patients with advanced solid tumors and in adult patients with recurrent or progressive glioblastoma or high-grade glioma. CCR4319
A Phase I, Multicentre Study to Assess the Safety, Tolerability, and Pharmacokinetics of ascending Doses of AZD1390 in Combination with Radiation Therapy in Patients with Glioblastoma Multiforme and Brain Metastases from Solid Tumors

Original classification

Early Phase Drug Development

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.